Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	215.36M
Revenue (ttm)	333.69M
Net Income (ttm)	9.55M
Shares Out	80.06M
EPS (ttm)	0.12
PE Ratio	22.54
Forward PE	19.21
Dividend	0.04 (1.50%)
Ex-Dividend Date	May 17, 2024

Volume	28,458
Average Volume	15,887
Open	2.680
Previous Close	2.660
Day's Range	2.630 - 2.690
52-Week Range	2.330 - 3.380
Beta	0.91
RSI	54.54
Earnings Date	Feb 28, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,331
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2023, Laboratorio Reig Jofre's revenue was 317.95 million, an increase of 15.95% compared to the previous year's 274.21 million. Earnings were 9.41 million, an increase of 16.04%.